Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor–Responsive NSCLC: A Case Report

As novel therapeutic regimens continue to lead to increased survival of patients with lung cancer, it is imperative to remain mindful of the accompanying increase in the incidence of new primary malignancies. Although the most common secondary malignancies in patients with lung cancer have historica...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheunkarndee, Tia, Guo, Matthew Z., Birkness-Gartman, Jacqueline E., Oshima, Kiyoko, Lin, Cheng Ting, Marrone, Kristen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883266/
https://www.ncbi.nlm.nih.gov/pubmed/36718141
http://dx.doi.org/10.1016/j.jtocrr.2022.100448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883266/
https://www.ncbi.nlm.nih.gov/pubmed/36718141
http://dx.doi.org/10.1016/j.jtocrr.2022.100448

Ejemplares similares